Helena Florindo, group leader of Drug Delivery & Immunoengineering Lab at iMed.ULisboa was awarded with a CaixaResearch Health 2022 grant from “la Caixa” Banking Foundation with the project titled Multifunctional nano-immunotherapy against breast brain metastases.
The project focuses on analysing the interactions established between the tumour, the vascular system and the immune system in metastatic brain cancers. The goal is to pave the way for the design of a new nano-immunotherapy that can regulate the brain’s immune function so that it prevents and treats brain metastases.
This project will be conducted at Helena Florindo’s Lab in collaboration with project partner Professor Ronit Satchi-Fainaro‘ team at Cancer Biology Research Center from Universidad de Tel Aviv, Israel.
Find more about the project here.
